WilmerHale Named Among Top Three Life Sciences Law Firms

WilmerHale Named Among Top Three Life Sciences Law Firms

Firm News

WilmerHale has been named among the top three Best Life Sciences Law Firms for 2016 in the inaugural Life Science Index. Litigation finance firm Lake Whillans launched the Index in collaboration with research partners at Breaking Media—the publisher of leading industry sites MedCity News and Above the Law. The Index identifies which law firms are the most active and relevant for life science companies. Along with the overall rankings, WilmerHale was selected as the top firm in the patent category. 

“Entrepreneurs in the life sciences space face a myriad of challenges—regulatory hurdles, funding, product development, clinical trials, intellectual property matters and much more,” said Lee Drucker, principal at Lake Whillans, as reported by Above the Law. “Having the right legal counsel as a partner can easily make or break a business venture. We created this index with the goal of helping startups, as well as more established companies, identify the top law firms with deep experience in every aspect of the life sciences life cycle.”

In addition to collecting data in three practice categories—corporate, intellectual property and regulatory—the index rankings incorporate information on firms' work with startup companies, as well as the firms' thought leadership efforts. The methodology behind the Index was designed to reflect a holistic view of the role of a law firm throughout the life cycle of a life sciences company: from inception through clinical trials. 

Visit lakewhillans.com to view the complete index and to learn about the research process.



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.